Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial

Imagem de Miniatura
Arquivos
art_GARZILLO_Long_term_analysis_of_left_ventricular_ejection_fraction_2013.PDF (420.59 KB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Autores
GERSH, Bernard J.
Citação
EUROPEAN HEART JOURNAL, v.34, n.43, p.3370-3377, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Assuming that coronary interventions, both coronary bypass surgery (CABG) and percutaneous coronary intervention (PCI), are directed to preserve left ventricular function, it is not known whether medical therapy alone (MT) can achieve this protection. Thus, we evaluated the evolution of LV ejection fraction (LVEF) in patients with stable coronary artery disease (CAD) treated by CABG, PCI, or MT as a post hoc analysis of a randomized controlled trial with a follow-up of 10 years. Methods Left ventricle ejection fraction was assessed with transthoracic echocardiography in patients with multivessel CAD, participants of the MASS II trial before randomization to CABG, PCI, or MT, and re-evaluated after 10 years of follow-up. Results Of the 611 patients, 422 were alive after 10.32 1.43 years. Three hundred and fifty had LVEF reassessed: 108 patients from MT, 111 from CABG, and 131 from PCI. There was no difference in LVEF at the beginning (0.61 0.07, 0.61 0.08, 0.61 0.09, respectively, for PCI, CABG, and MT, P 0.675) or at the end of follow-up (0.56 0.11, 0.55 0.11, 0.55 0.12, P 0.675), or in the decline of LVEF (reduction delta of 7.2 17.13, 9.08 18.77, and 7.54 22.74). Acute myocardial infarction (AMI) during the follow-up was associated with greater reduction in LVEF. The presence of previous AMI (OR: 2.50, 95 CI: 1.404.45; P 0.0007) and during the follow-up (OR: 2.73, 95 CI: 1.255.92; P 0.005) was associated with development of LVEF 45. Conclusion Regardless of the therapeutic option applied, LVEF remains preserved in the absence of a major adverse cardiac event after 10 years of follow-up.
Palavras-chave
Left ventricular ejection fraction, Coronary artery disease, Coronary bypass surgery, Percutaneous coronary intervention, Medical therapy
URI
https://observatorio.fm.usp.br/handle/OPI/3993
Referências
  1. BARI 2D Study Group, 2009, NEW ENGL J MED, V360, P2503
  2. Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
  3. Buszman P, 2009, CATHETER CARDIO INTE, V74, P420, DOI 10.1002/ccd.22015
  4. Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
  5. CAMPEAU L, 1976, CIRCULATION, V54, P522
  6. Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938
  7. Daemen J, 2008, CIRCULATION, V118, P1146, DOI 10.1161/CIRCULATIONAHA.107.752147
  8. Daly CA, 2006, BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE
  9. DETRE K, 1981, CIRCULATION, V63, P1329
  10. Douglas Jr JR, 1990, HEART, P2131
  11. Gibbons RJ, 2001, CIRCULATION, V103, P1076
  12. HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421
  13. Hochman J, STUDY IN PRESS
  14. Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
  15. Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
  16. JONES EL, 1980, ANN SURG, V192, P390, DOI 10.1097/00000658-198009000-00015
  17. LAKATTA EG, 1990, EUR HEART J, V11, P22
  18. Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
  19. MOCK MB, 1982, CIRCULATION, V66, P562
  20. Panza JA, 2010, EUR HEART J, V31, P905, DOI 10.1093/eurheartj/ehq044
  21. Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004
  22. Rosner B, 1986, FUNDAMENTALS BIOSTAT
  23. Rubinshtein R, 2010, EUR HEART J, V31, P936, DOI 10.1093/eurheartj/ehp459
  24. Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
  25. Shaw LJ, 2012, AM HEART J, V164, P243, DOI 10.1016/j.ahj.2012.05.018
  26. Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
  27. SoS Investigators, 2002, LANCET, V360, P965
  28. Stefanidis A, 2009, EUR J ECHOCARDIOGR, V10, P647, DOI 10.1093/ejechocard/jep026
  29. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators, 1996, N ENGL J MED, V335, P217
  30. Timm NH, 1975, MULTIVARIATE ANAL AP
  31. WEINER DA, 1984, J AM COLL CARDIOL, V3, P772

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - ODS/03